BRIEF

on HBM Healthcare Investments AG (ETR:CH001262)

HBM Healthcare Investments AG Reports Monthly Performance Figures

HBM Healthcare Investments AG released its key performance figures for February 2026, highlighting notable changes in its financial metrics. As of February 28, 2026, the Net Asset Value (NAV) per share stood at CHF 275.58, reflecting a month-to-date (MTD) decline of 1.6% and a calendar year-to-date (CYTD) decrease of 1.9%. The company's share price was recorded at CHF 222.00, marking a 7.5% drop MTD and a 2.0% decline CYTD.

Despite these declines, the figures also note a significant improvement of 15.8% in the fiscal year-to-date (FYTD) for NAV and a 26.8% increase for the share price. The total net assets were reported at CHF 1,826 million. HBM, headquartered in Zug, Switzerland, continues to monitor market conditions closely as it navigates its investment strategy.

R. E.

Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.

Click here to consult the press release on which this article is based

See all HBM Healthcare Investments AG news